Erratum to The emergence of new psychoactive substance (NPS) benzodiazepines: a review (Drug Testing and Analysis, (2018), 10, 1, (37-53), 10.1002/dta.2211)

Kieran R. Manchester; Emma C. Lomas; Laura Waters; Fiona C. Dempsey; Peter D. Maskell

doi:10.1002/dta.2349

Erratum to The emergence of new psychoactive substance (NPS) benzodiazepines: a review (Drug Testing and Analysis, (2018), 10, 1, (37-53), 10.1002/dta.2211)

Kieran R. Manchester, Emma C. Lomas, Laura Waters, Fiona C. Dempsey, Peter D. Maskell

Research output: Contribution to journal › Comment/debate

6 Citations (Scopus)

Abstract

This article corrects: Manchester KR, Lomas EC, Waters L, Dempsey FC, Maskell PD. The emergence of new psychoactive substance (NPS) benzodiazepines: A review. Drug Test Anal. 2018;10:392–393. https://doi.org/10.1002/dta.2211 References appearing in Table of this article were omitted from the original. Benzodiazepine patent years and EMCDDA report years (Table presented.).

Original language	English
Pages (from-to)	392-393
Number of pages	2
Journal	Drug Testing and Analysis
Volume	10
Issue number	2
DOIs	https://doi.org/10.1002/dta.2349
Publication status	Published - 1 Jan 2018

Access to Document

10.1002/dta.2349

Fingerprint Dive into the research topics of 'Erratum to The emergence of new psychoactive substance (NPS) benzodiazepines: a review (Drug Testing and Analysis, (2018), 10, 1, (37-53), 10.1002/dta.2211)'. Together they form a unique fingerprint.

Cite this

Manchester, K. R., Lomas, E. C., Waters, L., Dempsey, F. C., & Maskell, P. D. (2018). Erratum to The emergence of new psychoactive substance (NPS) benzodiazepines: a review (Drug Testing and Analysis, (2018), 10, 1, (37-53), 10.1002/dta.2211). Drug Testing and Analysis, 10(2), 392-393. https://doi.org/10.1002/dta.2349

@article{9e4b5ccac65e47928e385f0defe0cda4,

title = "Erratum to The emergence of new psychoactive substance (NPS) benzodiazepines: a review (Drug Testing and Analysis, (2018), 10, 1, (37-53), 10.1002/dta.2211)",

abstract = "This article corrects: Manchester KR, Lomas EC, Waters L, Dempsey FC, Maskell PD. The emergence of new psychoactive substance (NPS) benzodiazepines: A review. Drug Test Anal. 2018;10:392–393. https://doi.org/10.1002/dta.2211 References appearing in Table of this article were omitted from the original. Benzodiazepine patent years and EMCDDA report years (Table presented.).",

author = "Manchester, {Kieran R.} and Lomas, {Emma C.} and Laura Waters and Dempsey, {Fiona C.} and Maskell, {Peter D.}",

year = "2018",

month = jan,

day = "1",

doi = "10.1002/dta.2349",

language = "English",

volume = "10",

pages = "392--393",

journal = "Drug Testing and Analysis",

issn = "1942-7603",

publisher = "John Wiley and Sons Ltd",

number = "2",

}

Erratum to The emergence of new psychoactive substance (NPS) benzodiazepines : a review (Drug Testing and Analysis, (2018), 10, 1, (37-53), 10.1002/dta.2211). / Manchester, Kieran R.; Lomas, Emma C.; Waters, Laura; Dempsey, Fiona C.; Maskell, Peter D.

In: Drug Testing and Analysis, Vol. 10, No. 2, 01.01.2018, p. 392-393.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum to The emergence of new psychoactive substance (NPS) benzodiazepines

T2 - a review (Drug Testing and Analysis, (2018), 10, 1, (37-53), 10.1002/dta.2211)

AU - Manchester, Kieran R.

AU - Lomas, Emma C.

AU - Waters, Laura

AU - Dempsey, Fiona C.

AU - Maskell, Peter D.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - This article corrects: Manchester KR, Lomas EC, Waters L, Dempsey FC, Maskell PD. The emergence of new psychoactive substance (NPS) benzodiazepines: A review. Drug Test Anal. 2018;10:392–393. https://doi.org/10.1002/dta.2211 References appearing in Table of this article were omitted from the original. Benzodiazepine patent years and EMCDDA report years (Table presented.).

AB - This article corrects: Manchester KR, Lomas EC, Waters L, Dempsey FC, Maskell PD. The emergence of new psychoactive substance (NPS) benzodiazepines: A review. Drug Test Anal. 2018;10:392–393. https://doi.org/10.1002/dta.2211 References appearing in Table of this article were omitted from the original. Benzodiazepine patent years and EMCDDA report years (Table presented.).

U2 - 10.1002/dta.2349

DO - 10.1002/dta.2349

M3 - Comment/debate

AN - SCOPUS:85040704461

VL - 10

SP - 392

EP - 393

JO - Drug Testing and Analysis

JF - Drug Testing and Analysis

SN - 1942-7603

IS - 2

ER -